Determinants of the Cancer Drug Funding Process in Canada

Background: Canada has a publicly funded healthcare system with a complex drug funding process. After Health Canada approval to market a drug, the pan-Canadian Oncology Drug Review (pCODR) (now renamed the CADTH reimbursement review) makes a non-binding funding recommendation to the Canadian provinc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gotfrit, Joanna, Jackson, Ashley, Shin, John J. W., Stewart, David J., Mallick, Ranjeeta, Wheatley-Price, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946987/
https://www.ncbi.nlm.nih.gov/pubmed/35323362
http://dx.doi.org/10.3390/curroncol29030162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946987/
https://www.ncbi.nlm.nih.gov/pubmed/35323362
http://dx.doi.org/10.3390/curroncol29030162

Ejemplares similares